Top Markets
Coin of the day
QuantRx Biomedical Corporation QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB
Rang in aandelen #40578
QuantRx Biomedical Corporation is engaged in the creation and marketing of its... QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
Aandeelprijs
$0.0005
Laatst gesynchroniseerd: 2025-04-08
Marktkapitalisatie
$118.05K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel QuantRx Biomedical Corporation (QTXB)

Categorie

Aandelsplitsingen voor QuantRx Biomedical Corporation (QTXB)
Het aandeel QuantRx Biomedical Corporation (symbool: QTXB) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 13, 2026.
Eén aandeel QTXB dat vóór Aug 13, 2026 werd gekocht, staat nu gelijk aan 0 aandelen QTXB.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH